NEW YORK (GenomeWeb) – OpGen has been contracted to perform laboratory services as part of a Washington, DC citywide evaluation to gauge the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in healthcare facilities.

The evaluation is being led by the DC Department of Health and coordinated by the District of Columbia Hospital Association (DCHA), with an unspecific amount of funding from the US Centers for Disease Control and Prevention's Epidemiology and Laboratory Capacity for Infectious Diseases funding program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

The Economist writes that an increasing number of scientific journals don't do peer review.

In Science this week: genetic overlap among many psychiatric disorders, and more.

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research. 

Sponsored by

This online seminar will discuss the advantages of incorporating molecular testing into the microbiology laboratory to aid in the identification of relevant antibiotic resistance mechanisms.